Correlation analysis of the serum CD195 and Lipoxin A₄ levels with airway remodeling in bronchial asthma patients and nursing summary
Serum CD195 and Lipoxin A₄ levels with airway remodeling in bronchial asthma and nursing summary
Abstract
[Objective] To analyze the expression levels of serum chemokine receptor 5 (CCR5, CD195) and lipoxin A4 (LXA4) in patients with bronchial asthma and their correlations with immune dysfunction and airway remodeling.
[Methods] According to the severity of the disease, 240 patients with bronchial asthma admitted to our hospital from January 2023 to May 2025 were divided into mild to moderate asthma groups (n=180) and severe asthma groups (n=60). As the control group, 150 more healthy people who were admitted for a physical examination during that time were chosen. The serum CD195 and LXA4 levels and immune function indicators (CD3+, CD4+, CD8+, and CD4+/CD8+) of each group were detected, and the airway remodeling indicators [airway lumen area (LA), airway wall area (WA) and total airway area (TA)] of the right upper lobe tip segment were examined via CT. The correlations between the serum CD195 and LXA4 levels and immune dysfunction as well as airway remodeling were analyzed via a bivariate Spearman correlation test, and a multivariate logistic model was established to analyze the independent risk factors influencing the serum CD195 and LXA4 levels in patients with bronchial asthma.
[Results] Compared to the mild to moderate group, the severe group had greater serum levels of LXA4 and CD195. Serum CD195 was higher in the severe group than in the mild to moderate group, and LXA4 was lower in the severe group than in the mild to moderate group. There were statistically significant differences (P<0.05). Serum CD8+ T cell levels were higher than in the control group, whereas CD3+, CD4+, and CD4+/CD8+ T cell levels were lower in the mild to moderate and severe groups. Furthermore, the severe group had lower levels of CD3+, CD4+, and CD4+/CD8+ T cells than the mild to moderate group, whereas the mild to moderate group had greater levels of CD8+ T cells. The mild to moderate group of patients and the severe group of patients had lower levels of LA, WA, and TA in the right superior lobe apex segment than the control group, and patients in the severe group had lower levels of these three parameters than those in the mild to moderate group. There was a negative connection between serum CD195 and LXA4 and CD3+, CD4+, and CD4+/CD8+ (P<0.05) and a positive correlation with CD8+, LA, WA, and TA. Multivariate logistic regression analysis revealed that disease severity, CD3+, CD4+, CD8+, CD4+/CD8+, LA, WA, and TA were independent risk factors for increased serum CD195 and LXA4 in patients with bronchial asthma (P<0.05).
[Conclusion] Serum CD195 and LXA4 are closely related to the severity of bronchial asthma, immune dysfunction and airway remodeling.
References
2.Savin IA, Zenkova MA, Sen'kova AV. Bronchial Asthma, Airway Remodeling and Lung Fibrosis as Successive Steps of One Process. Int J Mol Sci. 2023 Nov 7;24(22):16042. doi: 10.3390/ijms242216042. PMID: 38003234; PMCID: PMC10671561.
3.Xu T, Wu Z, Yuan Q, Zhang X, Liu Y, Wu C, Song M, Wu J, Jiang J, Wang Z, Chen Z, Zhang M, Huang M, Ji N. Proline is increased in allergic asthma and promotes airway remodeling. JCI Insight. 2023 Aug 22;8(16):e167395. doi: 10.1172/jci.insight.167395. PMID: 37432745; PMCID: PMC10543727.
4.Domvri K, Tsiouprou I, Bakakos P, Steiropoulos P, Katsoulis K, Kostikas K, Antoniou KM, Papaioannou AI, Rovina N, Katsaounou P, Papamitsou T, Pastelli N, Tryfon S, Fouka E, Papakosta D, Loukides S, Porpodis K. Effect of mepolizumab in airway remodeling in patients with late-onset severe asthma with an eosinophilic phenotype. J Allergy Clin Immunol. 2025 Feb;155(2):425-435. doi: 10.1016/j.jaci.2024.10.024. Epub 2024 Nov 7. PMID: 39521278.
5.Yu X, Li L, Cai B, Zhang W, Liu Q, Li N, Shi X, Yu L, Chen R, Qiu C. Single-cell analysis reveals alterations in cellular composition and cell‒cell communication associated with airway inflammation and remodeling in asthma. Respir Res. 2024 Feb 5;25(1):76. doi: 10.1186/s12931-024-02706-4. PMID: 38317239; PMCID: PMC10845530.
6.Bajbouj K, AbuJabal R, Sahnoon L, Olivenstein R, Mahboub B, Hamid Q. IL-5 receptor expression in lung fibroblasts: Potential role in airway remodeling in asthma. Allergy. 2023 Mar;78(3):882-885. doi: 10.1111/all.15627. Epub 2023 Jan 4. PMID: 36575907.
7.Quan J, Xie D, Li Z, Yu X, Liang Z, Chen Y, Wu L, Huang D, Lin L, Fan L. Luteolin alleviates airway remodeling in asthma by inhibiting the epithelial–mesenchymal transition via β-catenin regulation. Phytomedicine. 2024 Dec;135:156090. doi: 10.1016/j.phymed.2024.156090. Epub 2024 Oct 3. PMID: 39393303.
8.Zhang N, Xu J, Jiang C, Lu S. Neuro-Immune Regulation in Inflammation and Airway Remodeling of Allergic Asthma. Front Immunol. 2022 Jun 16;13:894047. doi: 10.3389/fimmu.2022.894047. PMID: 35784284; PMCID: PMC9245431.
9.Bessonnat A, Hélie P, Grimes C, Lavoie JP. Airway remodeling in horses with mild and moderate asthma. J Vet Intern Med. 2022 Jan;36(1):285-291. doi: 10.1111/jvim.16333. Epub 2021 Dec 8. PMID: 34877706; PMCID: PMC8783337.
10.Tiotiu A, Steiropoulos P, Novakova S, Nedeva D, Novakova P, Chong-Neto H, Fogelbach GG, Kowal K. Airway Remodeling in Asthma: Mechanisms, Diagnosis, Treatment, and Future Directions. Arch Bronconeumol. 2025 Jan;61(1):31-40. English, Spanish. doi: 10.1016/j.arbres.2024.09.007. Epub 2024 Sep 24. PMID: 39368875.
11.Huang D, Bai S, Qiu G, Jiang C, Huang M, Wang Y, Zhong M, Fang J, Cheng J, Zhao X, Wu B, Wu D. Myricetin ameliorates airway inflammation and remodeling in asthma by activating Sirt1 to regulate the JNK/Smad3 pathway. Phytomedicine. 2024 Dec;135:156044. doi: 10.1016/j.phymed.2024.156044. Epub 2024 Sep 12. PMID: 39299094.
12.Xu L, Huang X, Chen Z, Yang M, Deng J. Eosinophil peroxidase promotes bronchial epithelial cells to secrete asthma-related factors and induces the early stage of airway remodeling. Clin Immunol. 2024 Jun;263:110228. doi: 10.1016/j.clim.2024.110228. Epub 2024 Apr 23. PMID: 38663494.
13.Wu L, Zheng Y, Liu J, Luo R, Wu D, Xu P, Wu D, Li X. Comprehensive evaluation of the efficacy and safety of LPV/r drugs in the treatment of SARS and MERS to provide potential treatment options for COVID-19. Aging (Albany NY). 2021 Apr 20;13(8):10833-10852. doi: 10.18632/aging.202860. Epub 2021 Apr 20. PMID: 33879634; PMCID: PMC8109137.
14.Wu L, Zhong Y, Wu D, Xu P, Ruan X, Yan J, Liu J, Li X. Immunomodulatory Factor TIM3 of Cytolytic Active Genes Affected the Survival and Prognosis of Lung Adenocarcinoma Patients by Multi-Omics Analysis. Biomedicines. 2022 Sep 10;10(9):2248. doi: 10.3390/biomedicines10092248. PMID: 36140350; PMCID: PMC9496572.
15.Alabed M, Elemam NM, Ramakrishnan RK, Sharif-Askari NS, Kashour T, Hamid Q, Halwani R. Therapeutic effect of statins on airway remodeling during asthma. Expert Rev Respir Med. 2022 Jan;16(1):17-24. doi: 10.1080/17476348.2021.1987890. Epub 2021 Oct 28. PMID: 34663161.
16.Ren K, Niu B, Liang H, Xi C, Song M, Chen J, Zhao F, Cao Z. Zhichuanling injection improves bronchial asthma by attenuation airway inflammation and epithelia-mesenchymal transition. J Ethnopharmacol. 2025 Mar 26;344:119540. doi: 10.1016/j.jep.2025.119540. Epub 2025 Feb 26. PMID: 40020793.
17.Shan L, Chen L, Shen W, Zhou Q, Liu S, Han L, Zhang Q, Dai B, Zhao Y. FOXK2 facilitates the airway remodeling during chronic asthma by promoting glycolysis in a SIRT2-dependent manner. FASEB J. 2024 Jul 15;38(13):e23756. doi: 10.1096/fj.202302284R. PMID: 38949649.
18.Wu L, Liu Q, Ruan X, Luan X, Zhong Y, Liu J, Yan J, Li X. Multiple Omics Analysis of the Role of RBM10 Gene Instability in Immune Regulation and Drug Sensitivity in Patients with Lung Adenocarcinoma (LUAD). Biomedicines. 2023 Jun 29;11(7):1861. doi: 10.3390/biomedicines11071861. PMID: 37509501; PMCID: PMC10377220.
19.Wang D, Cui Y, Gao F, Zheng W, Li J, Xian Z. Effects of imperatorin on airway remodeling in bronchial asthma through S1PR2/STAT3 signaling pathway. Cell Mol Biol (Noisy-le-grand). 2023 Dec 31;69(15):1-5. doi: 10.14715/cmb/2023.69.15.1. PMID: 38279507.
20.Jesenak M, Durdik P, Oppova D, Franova S, Diamant Z, Golebski K, Banovcin P, Vojtkova J, Novakova E. Dysfunctional mucociliary clearance in asthma and airway remodeling - New insights into an old topic. Respir Med. 2023 Nov;218:107372. doi: 10.1016/j.rmed.2023.107372. Epub 2023 Jul 27. PMID: 37516275.
21.Su ZQ, Zhou ZQ, Guan WJ, Fan MY, Rao WY, Chen Y, Chen XB, Zhong CH, Tang CL, Li SY, Zhong NS. Airway remodeling and bronchodilator responses in asthma assessed by endobronchial optical coherence tomography. Allergy. 2022 Feb;77(2):646-649. doi: 10.1111/all.15062. Epub 2021 Aug 31. PMID: 34437708.
22.Tsuge M, Ikeda M, Tsukahara H. Novel Lung Growth Strategy with Biological Therapy Targeting Airway Remodeling in Childhood Bronchial Asthma. Children (Basel). 2022 Aug 19;9(8):1253. doi: 10.3390/children9081253. PMID: 36010143; PMCID: PMC9406359.
23.Wu L, Zheng Y, Ruan X, Wu D, Xu P, Liu J, Wu D, Li X. Long-chain noncoding ribonucleic acids affect the survival and prognosis of patients with esophageal adenocarcinoma through the autophagy pathway: construction of a prognostic model. Anticancer Drugs. 2022 Jan 1;33(1):e590-e603. doi: 10.1097/CAD.0000000000001189. PMID: 34338240; PMCID: PMC8670349.
24.Yuan L, Qin Q, Yao Y, Chen L, Liu H, Du X, Ji M, Wu X, Wang W, Qin Q, Xiang Y, Qing B, Qu X, Yang M, Qin X, Xia Z, Liu C. Increased expression of cathepsin C in airway epithelia exacerbates airway remodeling in asthma. JCI Insight. 2024 Nov 22;9(22):e181219. doi: 10.1172/jci.insight.181219. PMID: 39436705; PMCID: PMC11601913.
25.Schiffer M, Peters K, Peters M. Comparison of Airway Remodeling in Two Different Endotypes of Allergic Asthma. Int Arch Allergy Immunol. 2022;183(7):714-725. doi: 10.1159/000522189. Epub 2022 Feb 22. PMID: 35193134.
26.Sahnoon L, Bajbouj K, Mahboub B, Hamoudi R, Hamid Q. Targeting IL-13 and IL-4 in Asthma: Therapeutic Implications on Airway Remodeling in Severe Asthma. Clin Rev Allergy Immunol. 2025 Apr 21;68(1):44. doi: 10.1007/s12016-025-09045-2. PMID: 40257546; PMCID: PMC12011922.
27.Wu L, Li H, Liu Y, Fan Z, Xu J, Li N, Qian X, Lin Z, Li X, Yan J. Research progress of 3D-bioprinted functional pancreas and in vitro tumor models. International Journal of Bioprinting. 2024, 10(1), 1256. doi: 10.36922/ijb.1256.
28.Wu L, Zhong Y, Yu X, Wu D, Xu P, Lv L, Ruan X, Liu Q, Feng Y, Liu J, Li X. Selective poly adenylation predicts the efficacy of immunotherapy in patients with lung adenocarcinoma by multiple omics research. Anticancer Drugs. 2022 Oct 1;33(9):943-959. doi: 10.1097/CAD.0000000000001319. Epub 2022 Aug 9. PMID: 35946526; PMCID: PMC9481295.
29.Galvão JGFM, Cavalcante-Silva LHA, de Almeida Lima É, Carvalho DCM, Alves AF, Mascarenhas SR. Ouabain modulates airway remodeling caused by Th2-high asthma in mice. Int Immunopharmacol. 2022 Aug;109:108808. doi: 10.1016/j.intimp.2022.108808. Epub 2022 Apr 30. PMID: 35504206.
30.Zhang M, Zhou JX, Huang CQ, Feng KN, Zou XL, Cen JM, Meng P, Li HT, Zhang TT. IL-38 alleviates airway remodeling in chronic asthma by blocking the profibrotic effect of IL-36γ. Clin Exp Immunol. 2023 Dec 13;214(3):260-274. doi: 10.1093/cei/uxad099. PMID: 37586814; PMCID: PMC10719219.
31.Ghosh S. Computed tomography findings in bronchial asthma: quantification of air trapping and correlation with pulmonary function tests. Acta Radiol. 2023 Apr;64(4):1418-1421. doi: 10.1177/02841851221135233. Epub 2022 Oct 31. PMID: 36317289.
32.Wu L, Li X, Qian X, Wang S, Liu J, Yan J. Lipid Nanoparticle (LNP) Delivery Carrier-Assisted Targeted Controlled Release mRNA Vaccines in Tumor Immunity. Vaccines (Basel). 2024 Feb 12;12(2):186. doi: 10.3390/vaccines12020186. PMID: 38400169; PMCID: PMC10891594.
33.Behluli E, Spahiu L, Ismaili-Jaha V, Neziri B, Temaj G. Correlation between level of vitamin D in serum and value of lung function in children diagnosed with bronchial asthma. Folia Med (Plovdiv). 2022 Aug 31;64(4):649-654. doi: 10.3897/folmed.64.e67800. PMID: 36045472.
34.Wu D, Wang J, Wei Y, Zhang X, Hou Z. Correlation Analysis of Serum 25-Hydroxyvitamin D Levels With Immune Function and Calcium-Phosphate Metabolism in Patients With Bronchial Asthma Treated With Combination Therapy. Physiol Res. 2024 Nov 19;73(5):841-855. doi: 10.33549/physiolres.935279. PMID: 39560193; PMCID: PMC11629948.
35.Eltokhy AK, Toema O, El-Deeb OS. The Correlation Between PINK-1/Parkin Mediated Mitophagy, Endoplasmic Reticulum Stress and Total Polyamines in Pediatric Bronchial Asthma: An Integrated Network of Pathways. Mol Biol Rep. 2022 Jan;49(1):227-235. doi: 10.1007/s11033-021-06861-5. Epub 2021 Oct 29. PMID: 34714483.
36.Scaramozzino MU, Festa M, Levi G, Plastina UR, Sapone G. Correlation between gastroesophageal reflux disease lung volumes and exacerbation of bronchial asthma: Italian pilot observational retrospective study GERDAS. Monaldi Arch Chest Dis. 2023 Jun 15;94(2). doi: 10.4081/monaldi.2023.2640. PMID: 37325973.
37.Zhu Y, Huang B, Jiang G. Correlation between changes in serum YKL-40, LXRs, PPM1A, and TGF-β1 levels and airway remodeling and lung function in patients with bronchial asthma. J Asthma. 2024 Jul;61(7):698-706. doi: 10.1080/02770903.2023.2301426. Epub 2024 Feb 8. PMID: 38164946.
Copyright (c) 2026 Haiyue Huang, Ruirui Luo, Xuan Yang, Zhigang Wu, Zhongxi Ding
This work is licensed under a Creative Commons Attribution 4.0 International License.
The published articles will be distributed under the Creative Commons Attribution 4.0 International License (CC BY). It is allowed to copy and redistribute the material in any medium or format, and remix, transform, and build upon it for any purpose, even commercially, as long as appropriate credit is given to the original author(s), a link to the license is provided and it is indicated if changes were made. Users are required to provide full bibliographic description of the original publication (authors, article title, journal title, volume, issue, pages), as well as its DOI code. In electronic publishing, users are also required to link the content with both the original article published in Journal of Medical Biochemistry and the licence used.
Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgement of its initial publication in this journal.